← Back to headlines

ATTAIN-2: Lilly’s Orforglipron Matches Injectable GLP-1s for Weight and A1C Reduction

This story is reported by Docwire News. Read what other outlets are saying below, then open the original report for full details.

ATTAIN-2: Lilly’s Orforglipron Matches Injectable GLP-1s for Weight and A1C Reduction · NabkaNews